OSTEOwelt
OSTEOwelt TCP is developed as synthetic bone graft substitute and composed of > 95 % TCP & Silicate.
Specialty:
View this product at biolotmedical.com
Global Medical Directory is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
OSTEOwelt TCP is developed as synthetic bone graft substitute and composed of > 95 % TCP & Silicate.